Ghiath M. Sukhtian bought $5M of OTLK stock

Ghiath M. Sukhtian, Dir, 10% of Outlook Therapeutics, Inc. (OTLK), bought 8,539,709 shares of OTLK stock worth $5M, per an SEC Form 4 filed Jun 2, 2026.

The shares came through a private deal, not the open market.

The trade happened on May 28, 2026, 5 days before it was made public.

OTLK has moved -44.2% since the trade date, from $0.74 to $0.41 (Nov 13, 2026 close).